Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer - Related Studies

Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer

This study is ongoing, but not recruiting participants.

Study NCT00003427. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Anal Cancer
		Colorectal Cancer
		Esophageal Cancer
		Extrahepatic Bile Duct Cancer
		Gallbladder Cancer
		Gastric Cancer
		Gastrointestinal Carcinoid Tumor
		Liver Cancer
		Pancreatic Cancer
		Small Intestine Cancer

2	Additional conditions recognized in this trial
		Anus Neoplasms
		Bile Duct Neoplasms
		Carcinoid Tumor
		Colorectal Neoplasms
		Duodenal Neoplasms
		Esophageal Diseases
		Esophageal Neoplasms
		Gallbladder Neoplasms
		Gastrointestinal Neoplasms
		Ileal Neoplasms
		Intestinal Neoplasms
		Jejunal Neoplasms
		Liver Neoplasms
		Malignant Carcinoid Syndrome
		Pancreatic Neoplasms
		Stomach Neoplasms

3	More general conditions related to this trial
		Adenocarcinoma
		Anus Diseases
		Bile Duct Diseases
		Biliary Tract Diseases
		Biliary Tract Neoplasms
		Carcinoma
		Colonic Diseases
		Digestive System Diseases
		Digestive System Neoplasms
		Duodenal Diseases
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Gallbladder Diseases
		Gastrointestinal Diseases
		Head and Neck Neoplasms
		Ileal Diseases
		Intestinal Diseases
		Jejunal Diseases
		Liver Diseases
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Glandular and Epithelial
		Neoplasms, Nerve Tissue
		Neuroectodermal Tumors
		Neuroendocrine Tumors
		Pancreatic Diseases
		Rectal Diseases
		Rectal Neoplasms
		Stomach Diseases

4	Interventions listed in this trial
		irinotecan hydrochloride
		oxaliplatin

5	Additional drug interventions recognized in this trial
		Camptothecin
		Irinotecan

6	More general drug interventions related to this trial
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses

7	Sponsors listed in this trial
		Memorial Sloan-Kettering Cancer Center
		National Cancer Institute (NCI)